Vertex Pharmaceuticals Incorporated (VRTX) Latest Stock News ...
Get the latest Vertex Pharmaceuticals Incorporated (VRTX) stock news and headlines to help you in your trading and investing decisions.
Vertex Pharmaceuticals Incorporated (VRTX) - Yahoo Finance
Find the latest Vertex Pharmaceuticals Incorporated (VRTX) stock quote, history, news and other vital information to help you with your stock trading and investing.
Vertex Pharmaceuticals (VRTX) News Today - MarketBeat
5 days ago · What's going on at Vertex Pharmaceuticals (NASDAQ:VRTX)? Read today's VRTX news from trusted media outlets at MarketBeat.
Vertex Announces US FDA Approval of ALYFTREK™, a Once-Daily …
Dec 20, 2024 · Vertex Announces US FDA Approval of ALYFTREK™, a Once-Daily Next-in-Class CFTR Modulator for the Treatment of Cystic Fibrosis - ALYFTREK ™ is approved for patients 6 years and older with at least one responsive mutation, including 31 additional mutations not responsive to other CFTR modulator therapies -
Press Releases - Vertex Pharmaceuticals Newsroom
Oct 25, 2024 · BOSTON --(BUSINESS WIRE)--Oct. 10, 2024-- Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) will report its third quarter 2024 financial results on Monday, November 4, 2024 after the financial markets close. The company will host a conference call and webcast at 4:30 p.m. ET .
News & Events - Vertex Pharmaceuticals
Jul 30, 2024 · Suzetrigine has the potential to be the first new class of medicine to treat acute pain in over twenty years. The FDA has granted suzetrigine priority review and assigned a Prescription Drug User Fee Act (PDUFA) target action date of January 30, 2025.
Vertex Pharmaceuticals Incorporated (VRTX) Stock Price, News, …
Find the latest Vertex Pharmaceuticals Incorporated (VRTX) stock quote, history, news and other vital information to help you with your stock trading and investing.
Vertex Reports Third Quarter 2024 Financial Results
Sep 30, 2024 · BOSTON--(BUSINESS WIRE)--Nov. 4, 2024-- Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today reported consolidated financial results for the third quarter ended September 30, 2024, and raised its full-year product revenue guidance to …
Vertex Pharmaceuticals Incorporated (VRTX) Latest Stock News
Get the latest news and real-time alerts from Vertex Pharmaceuticals Incorporated (VRTX) stock at Seeking Alpha.
News & Events - Vertex Pharmaceuticals
Feb 5, 2024 · To access the call, please dial (833) 630-2124 (U.S.) or +1(412) 317-0651 (International) and reference the “Vertex Pharmaceuticals Fourth Quarter 2023 Earnings Call.” The conference call will be webcast live and a link to the webcast can be accessed through Vertex 's website at www.vrtx.com in the "Investors" section. To ensure a timely ...